pentobarbital will lessen the level or result of pimozide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Not known.

pentobarbital will reduce the level or influence of eletriptan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.

benzhydrocodone/acetaminophen and pentobarbital both boost sedation. Steer clear of or Use Alternate Drug. Limit use to patients for whom substitute remedy choices are inadequate

pentobarbital will minimize the extent or impact of zolpidem by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Not known.

pentobarbital will minimize the extent or outcome of zonisamide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unidentified.

Pentobarbital administration is thru IM, IV, or oral routes. For IM administration, injecting no more than five mL and only into a substantial muscle to prevent tissue discomfort or necrosis is recommended.

pentobarbital will minimize the level or influence of buprenorphine buccal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

Keep an eye on Intently (1)pentobarbital will decrease the level or result of glecaprevir/pibrentasvir by influencing hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will reduce the level or impact of buprenorphine get more info subdermal implant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Intently. Observe sufferers currently on buprenorphine subdermal implant who demand newly-initiated therapy with CYP3A4 inducer for signs and signs and symptoms of withdrawal.

Your physician or slumber specialist can even probably complete a medical Test. Your health practitioner will pay attention to your heart and lungs, and perform other routine screening steps for health conditions that may be producing your insomnia.

pentobarbital will lessen the extent or result of cilostazol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.

pentobarbital will lessen the extent or influence of verapamil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.

Contraindicated (1)pentobarbital will decrease the level or result of lonafarnib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is usually a sensitive CYP3A4 substrate. Coadministration with solid or average CYP3A4 inducers is contraindicated.

pentobarbital will decrease the extent or effect of clarithromycin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Mysterious.